AXP
stock NYSEKey stats
- Open
- $308.55
- -0.41%
- Close
- $309.70
- -0.04%
- Current
- $309.70
- Prev close
- $309.82
- Today
- 1.99M
- 3-mo avg
- 3.66M
Fundamentals
Each ratio reads FY2025 figures against the latest price, graded so the quality shows at a glance.
At 20x, the price is a reasonable multiple of the company's annual profit.
Share price divided by earnings per share: what you pay for each $1 of yearly profit. Roughly 15 to 25 is typical, above 40 is richly priced, and negative means the company is losing money.
A 1.1% yield is modest: a small income on top of whatever the share price does.
The yearly dividend as a percent of the share price: the cash income each share pays out. Around 2 to 6% is healthy; above roughly 8% often signals the payout may be cut.
A 26.2% margin is strong; the company keeps a healthy slice of every revenue dollar.
The share of revenue left as profit once every cost is paid. Above 15% is strong; below 5% leaves little cushion against a bad year.
A 32.4% return on equity is strong; the company compounds owners' capital well.
Profit earned on each dollar of shareholder equity: how well the company compounds its owners' capital. Above 15% is strong.
A 3.6% return on assets is reasonable for a company of this kind.
Profit earned on each dollar of assets: how efficiently the whole asset base is used. Above 8% is strong.
At 7.96, the company leans heavily on borrowing, which adds risk if results weaken.
Total liabilities divided by shareholder equity: how heavily the company leans on borrowing. Below 1 is conservative; above 2 is highly leveraged.
This company does not report a current-assets breakdown, so the ratio cannot be computed.
Current assets divided by current liabilities: whether short-term resources cover short-term bills. Above 1.5 is comfortable; below 1 is tight.
Revenue grew 6.4% from the prior year: steady, modest expansion.
Change in annual revenue from the prior fiscal year: whether the top line is expanding. Above 10% is strong growth; below 0 means revenue is shrinking.
Net income grew 7.0% from the prior year: steady profit expansion.
Change in annual net income from the prior fiscal year: whether profit is expanding. Above 10% is strong; below 0 means profit is falling.
Financials
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | |
|---|---|---|---|---|---|
| Revenue | $27.7B | $34.2B | $37.2B | $38.8B | $41.3B |
| Net income | $8.1B | $7.5B | $8.4B | $10.1B | $10.8B |
| Diluted EPS | $10.02 | $9.85 | $11.21 | $14.01 | $15.38 |
| Dividend / share | $1.72 | $2.08 | $2.40 | $2.80 | $3.28 |
| Total assets | $189.0B | $228.4B | $261.1B | $271.5B | $300.1B |
| Total liabilities | $166.4B | $203.6B | $233.1B | $241.2B | $266.6B |
| Shareholder equity | $22.2B | $24.7B | $28.1B | $30.3B | $33.5B |
| Q3-2023 | Q1-2024 | Q2-2024 | Q3-2024 | Q1-2025 | Q2-2025 | Q3-2025 | Q1-2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $9.4B | $9.3B | $9.8B | $9.7B | $9.6B | $10.3B | $10.4B | $10.5B |
| Net income | $2.5B | $2.4B | $3.0B | $2.5B | $2.6B | $2.9B | $2.9B | $3.0B |
| Diluted EPS | $3.30 | $3.33 | $4.15 | $3.49 | $3.64 | $4.08 | $4.14 | $4.28 |
| Dividend / share | $0.60 | $0.70 | $0.70 | $0.70 | $0.82 | $0.82 | $0.82 | $0.95 |
Recent SEC filings
- 8-K Current report
- 8-K Current report
- 8-K Current report
- 8-K Current report
- 10-Q Quarterly report
- 8-K Current report
- 8-K Current report
- DEF 14A Proxy statement
- 8-K Current report
- 8-K Current report
- 8-K Current report
- 8-K Current report
- 8-K Current report
- 10-K Annual report
- 8-K Current report
- 8-K Current report
- 8-K Current report
- 8-K Current report